Tata Chemicals Limited Intrinsic Value

TATACHEM · Chemicals · Current price ₹633.55

Full stock page
DocStoX fair value
₹762
low confidence · 40/100
Current price
₹612
Upside to fair value
+24.4%
Estimate range
₹685 – ₹838
Quality score
3.2 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with Tata Chemicals Limited's latest numbers.

Is Tata Chemicals Limited undervalued?

We estimate the fair value of Tata Chemicals Limited at ₹762 per share, against a market price of ₹612. That puts the share price about +24.4% below our estimate, at low confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.

How this fair value is calculated

This estimate comes from 1 method: Normalized earnings (mid-cycle EV/EBITDA) (₹762). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.

The range around this estimate

Our estimate for Tata Chemicals Limited spans ₹685 to ₹838. That range is wide, which is the honest signal here: read the range rather than the single number. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.

Margin of safety

Value investors look for a margin of safety: a discount to estimated value that absorbs being wrong. At ₹612 against an estimated value of ₹762, Tata Chemicals Limited trades at +24.4%, i.e. a discount to our estimate. How much margin to demand depends on how much you trust the inputs, which is what the confidence band below is for.

How we got this fair value

Every number below is part of the same estimate for Tata Chemicals Limited. Nothing here is a target price or a forecast of where the share price will go.

Low confidence40/100

The inputs are thin or the models disagree sharply. This is our least reliable kind of estimate, so read the range rather than the single number.

Estimate range ₹685 – ₹838

Why this method for this business

Tata Chemicals is a cyclical commodity chemical company, so normalized mid-cycle earnings and EV/EBITDA are the most appropriate models. These models reflect the company's exposure to commodity price cycles and its capital intensity.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Normalized earnings (mid-cycle EV/EBITDA)
₹76270% weight

Cyclical valued off mid-cycle earnings and a through-cycle EV/EBITDA (§6.6)

EV / EBITDA(not enough data)

required inputs missing

  • relative_pe: Not suitable for cyclical commodities
  • normalized_earnings: Already used as primary model

What was missing

  • Forward EPS estimates for 2027
  • Detailed analysis of Kenya's regulatory impact
  • Long-term commodity price forecasts

What drives it

7 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Revenue (TTM)
14,584 ₹ cr

computed

Net debt
7,774 ₹ cr

computed

Shares outstanding
25,48,35,997

computed

AssumptionA forward input the model chose. Reasonable people can disagree here.
EBITDA margin (cycle median)
18%

computed (≤5y median)

Through-cycle EV/EBITDA
10.35×

own-history (median of 5y)

DerivedFalls out of the inputs above: a model output, not an independent input.
Mid-cycle EBITDA
2,625.1 ₹ cr

computed

Enterprise value
27,182.3 ₹ cr

computed

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Tata Chemicals Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Tata Chemicals Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.